For survival, embryonic motoneurons in vertebrates depend on as yet un
defined neurotrophic factors present in the limb bud. Members of the n
eurotrophin family are currently the best candidates for such neurotro
phic factors, but inactivation of their receptor genes leads to only p
artial loss of motoneurons, which suggests that other factors are invo
lved. Glial cell line-derived neurotrophic factor (GDNF), originally i
dentified as a trophic factor specific for dopaminergic neurons, was f
ound to be 75-fold more potent than the neurotrophins in supporting th
e survival of purified embryonic rat motoneurons in culture. GDNF mess
enger RNA was found in the immediate vicinity of motoneurons during th
e period of cell death in development. In vivo, GDNF rescues and preve
nts the atrophy of facial motoneurons that have been deprived of targe
t-derived survival factors by axotomy. GDNF may therefore be a physiol
ogical trophic factor for spinal motoneurons. Its potency and specific
ity in vitro and in vivo also make it a good candidate for treatment o
f motoneuron disease.